secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2023-03-22T23:59:59+00:00
Accession:  0001193125-23-076714
Event type: m_and_a
Sentiment:  negative
Materiality: 0.90
Item codes: 2.01, 3.01, 9.01, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica closes reverse merger with Graybug; Nasdaq delisting notice received for failing initial listing criteria
--------------------------------------------------------------------------------

- Merger closed March 20, 2023; 3.95M shares issued to CalciMedica stockholders; CalciMedica equityholders own ~72% of combined company.
- Company renamed CalciMedica, Inc.; ticker changes to CALC on March 21, 2023, but Nasdaq staff determined it fails initial listing requirements.
- Nasdaq suspension scheduled for March 30; Company will appeal and intends to trade on OTCQB if unsuccessful.
- New board and executive team from CalciMedica: CEO A. Rachel Leheny, COO Michael Dunn, CFO Daniel Geffken; prior Graybug CEO and CFO terminated.
- Pre-merger private placement raised $10.3M from ~20.7M shares of CalciMedica common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/0001193125-23-076714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523076714/d485425d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-076714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer